Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
49.37
-2.98 (-5.69%)
At close: May 30, 2025, 4:00 PM
49.95
+0.58 (1.17%)
After-hours: May 30, 2025, 7:59 PM EDT
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
$589,029
Profits / Employee
$82,148
Market Cap
120.98B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
SNY News
- 18 hours ago - Sanofi: Finding Value In The Wake Of Itepekimab's Disappointment - Seeking Alpha
- 1 day ago - Itepekimab Failure A Setback For Sanofi And Regeneron - Seeking Alpha
- 2 days ago - Sanofi, Regeneron's Itepekimab Delivers Mixed Results in Late-Stage Trials - WSJ
- 2 days ago - Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs - GlobeNewsWire
- 4 days ago - US FDA approves use of Sanofi's meningococcal vaccine in infants - Reuters
- 5 days ago - C4X Discovery receives latest milestone payment from Sanofi - GlobeNewsWire
- 5 days ago - Sanofi, VNVC launch vaccine factory in Vietnam - Reuters
- 5 days ago - Press Release: Sanofi completes acquisition of DR-0201 - GlobeNewsWire